WO2019045467A3 - 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 - Google Patents

항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 Download PDF

Info

Publication number
WO2019045467A3
WO2019045467A3 PCT/KR2018/010028 KR2018010028W WO2019045467A3 WO 2019045467 A3 WO2019045467 A3 WO 2019045467A3 KR 2018010028 W KR2018010028 W KR 2018010028W WO 2019045467 A3 WO2019045467 A3 WO 2019045467A3
Authority
WO
WIPO (PCT)
Prior art keywords
flatfish
paste
hydrolysates
fractions
peptides isolated
Prior art date
Application number
PCT/KR2018/010028
Other languages
English (en)
French (fr)
Other versions
WO2019045467A2 (ko
WO2019045467A9 (ko
Inventor
전유진
오재영
Original Assignee
제주대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020170111310A external-priority patent/KR101921214B1/ko
Priority claimed from KR1020170111944A external-priority patent/KR101918692B1/ko
Application filed by 제주대학교 산학협력단 filed Critical 제주대학교 산학협력단
Priority to US16/609,807 priority Critical patent/US11541099B2/en
Priority to JP2019558790A priority patent/JP7144441B2/ja
Publication of WO2019045467A2 publication Critical patent/WO2019045467A2/ko
Publication of WO2019045467A3 publication Critical patent/WO2019045467A3/ko
Publication of WO2019045467A9 publication Critical patent/WO2019045467A9/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4826Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/20Fish extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/70Comminuted, e.g. emulsified, fish products; Processed products therefrom such as pastes, reformed or compressed products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/40Table salts; Dietetic salt substitutes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/02Recovery or refining of essential oils from raw materials
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fish Paste Products (AREA)

Abstract

본 발명은 광어 연육의 가수분해물의 분획물에서 분리된 펩티드를 유효성분으로 포함하는, 고혈압 치료 또는 예방용 약학 조성물 또는 식품 조성물에 관한 것으로, 광어 연육이 혈압강하 효과를 가지고, 광어 연육의 가수분해물, 상기 광어 연육의 가수분해물의 분획물과 상기 분획물에서 분리된 펩티드가 안지오텐신 I 전환 효소 (Angiotensin I converting Enzyme, ACE) 저해 활성을 가지는 것을 확인하였다. 따라서, 상기 광어 연육의 가수분해물의 분획물에서 분리된 펩티드들을 이용하여, 고혈압 치료 또는 예방용 약학 조성물 또는 식품 조성물에 사용할 수 있다. 또한, 본 발명은 광어 연육의 가수분해물과 이에서 분리된 펩티드가 라디칼 소거 효과, 산화적 스트레스에 대한 보호 효과를 가지고 ROS 생성을 억제하고, 지질 과산화 그리고 세포사멸을 억제하는 것을 확인하였다. 따라서, 상기 광어 연육의 가수분해물의 분획물에서 분리된 펩티드들을 이용하여, 항산화용 식품 조성물에 사용할 수 있다.
PCT/KR2018/010028 2017-08-31 2018-08-30 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법 WO2019045467A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16/609,807 US11541099B2 (en) 2017-08-31 2018-08-30 Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same
JP2019558790A JP7144441B2 (ja) 2017-08-31 2018-08-30 抗酸化及び抗高血圧効果を有するヒラメ練肉及びその製造方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR1020170111310A KR101921214B1 (ko) 2017-08-31 2017-08-31 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법
KR10-2017-0111310 2017-08-31
KR10-2017-0111944 2017-09-01
KR1020170111944A KR101918692B1 (ko) 2017-09-01 2017-09-01 항산화 효과를 가지는 광어 연육 및 이의 제조방법

Publications (3)

Publication Number Publication Date
WO2019045467A2 WO2019045467A2 (ko) 2019-03-07
WO2019045467A3 true WO2019045467A3 (ko) 2019-05-09
WO2019045467A9 WO2019045467A9 (ko) 2019-07-11

Family

ID=65525795

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/010028 WO2019045467A2 (ko) 2017-08-31 2018-08-30 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법

Country Status (3)

Country Link
US (1) US11541099B2 (ko)
JP (1) JP7144441B2 (ko)
WO (1) WO2019045467A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114480538A (zh) * 2021-12-24 2022-05-13 海南三元星生物科技股份有限公司 一种海洋生物抗氧化活性肽组合物及其制备方法
CN116284341B (zh) * 2023-02-20 2024-05-03 中国石油大学(华东) 一种低免疫原性、降血压、抗氧化的深海鱼皮胶原蛋白肽制备及应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100600578B1 (ko) * 2004-04-12 2006-07-13 부경대학교 산학협력단 가자미 프레임으로부터 분리한 가수분해물 및 이를함유하는 항고혈압 조성물
KR100946997B1 (ko) * 2007-11-28 2010-03-10 강원도 인제군 황태 가수분해물, 2차 가수분해물 또는 이로부터 분리한활성 펩티드를 유효성분으로 함유하는 조성물
KR101404850B1 (ko) * 2012-10-09 2014-06-09 한국기초과학지원연구원 클로렐라 유래 항고혈압 활성을 갖는 펩티드
KR101449804B1 (ko) * 2012-09-12 2014-10-13 부경대학교 산학협력단 홍어 껍질 유래 젤라틴 추출물 및 상기 추출물로부터 분리한 펩타이드를 유효성분으로 포함하는 항고혈압 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10182696A (ja) * 1996-12-27 1998-07-07 Teikoku Seiyaku Co Ltd gp120に対して親和性を有するペプチド
JP3148153B2 (ja) * 1997-07-03 2001-03-19 株式会社分子バイオホトニクス研究所 紫外線吸収検出等電点電気泳動用マーカー
JP3271961B2 (ja) 2000-03-27 2002-04-08 和田八蒲鉾製造株式会社 魚肉練り製品及びその製造方法
ES2375351T3 (es) * 2002-04-01 2012-02-29 Agensys, Inc. Ácido nucleico y proteína correspondiente denominada 238p1b2 útil en el tratamiento y la detección de cáncer.
KR101201432B1 (ko) * 2010-08-12 2012-11-14 류홍수 제주산 광어를 이용하여 파우치형 광어고음 및 그의 제조방법
KR102017026B1 (ko) * 2013-01-10 2019-09-02 (주) 수파드엘릭사 염증 또는 알러지의 예방 또는 치료용 약학 조성물 및 염증 또는 알러지 개선용 화장료 조성물
US9951371B2 (en) * 2014-09-17 2018-04-24 Northwestern University Probes and assays for measuring E3 ligase activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100600578B1 (ko) * 2004-04-12 2006-07-13 부경대학교 산학협력단 가자미 프레임으로부터 분리한 가수분해물 및 이를함유하는 항고혈압 조성물
KR100946997B1 (ko) * 2007-11-28 2010-03-10 강원도 인제군 황태 가수분해물, 2차 가수분해물 또는 이로부터 분리한활성 펩티드를 유효성분으로 함유하는 조성물
KR101449804B1 (ko) * 2012-09-12 2014-10-13 부경대학교 산학협력단 홍어 껍질 유래 젤라틴 추출물 및 상기 추출물로부터 분리한 펩타이드를 유효성분으로 포함하는 항고혈압 조성물
KR101404850B1 (ko) * 2012-10-09 2014-06-09 한국기초과학지원연구원 클로렐라 유래 항고혈압 활성을 갖는 펩티드

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KO, JU-YOUNG: "Small molecular preparation of flounder fish(Paralichthys olivaceus) muscle and its biological activities", MASTER`S THESIS, February 2011 (2011-02-01) *

Also Published As

Publication number Publication date
WO2019045467A2 (ko) 2019-03-07
US20200179481A1 (en) 2020-06-11
JP7144441B2 (ja) 2022-09-29
US11541099B2 (en) 2023-01-03
WO2019045467A9 (ko) 2019-07-11
JP2020518572A (ja) 2020-06-25

Similar Documents

Publication Publication Date Title
CR20210415A (es) Compuestos de 3-carbonilamino-5-ciclopentil-1h-pirazol que tienen actividad inhibidoria en cdk2
CA3148745A1 (en) Kras g12d inhibitors
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
JOP20190281A1 (ar) مشتق n2، n4 ثنائي فينيل بيريميدين -2، 4- ثنائي أمين، وطريقة لتحضيره، وتركيبة صيدلانية تحتوي على المشتق بوصفه مكون فعال للوقاية من السرطان أو علاجه
PH12016501357B1 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
EP4011376A3 (en) Combination of an alk inhibitor and an egfr inhibitor for treating cancer
WO2019043450A3 (en) COSMETIC COMPOSITIONS HAVING ANTIOXIDANT PROPERTIES
WO2011159137A3 (ko) 신규한 티오우레아 또는 우레아 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 aids 예방 또는 치료용 약학 조성물
EP4400098A3 (en) Co-amorphous forms of beta-lactoglobulin and a drug substance
WO2019045467A3 (ko) 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법
CA3155883A1 (en) BUCCO-DENTAL CARE COMPOSITIONS BASED ON BETA ACID OF HOPS AND AMINO ACID
ZA202300259B (en) Compound for the treatment of coronaviral infections
EP4008718A4 (en) HETEROARYLAMIDOPYRIDINOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM FOR THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES
JOP20210295A1 (ar) أشكال صلبة لمثبط GlyT1
PH12021550122A1 (en) Solubilized apyrases, methods and use
PH12021551070A1 (en) Pharmaceutical composition comprising histone deacetylase 6 inhibitors
WO2019022482A3 (ko) 황칠나무 추출물을 유효성분으로 포함하는 섬유화 질환의 예방 또는 치료용 조성물
WO2019013495A3 (ko) 민들레 추출물 및 레몬밤 추출물을 포함하는 간 보호용 조성물
EP4005572A4 (en) BENZAMIDE DERIVATIVE, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION COMPRISING IT AS AN ACTIVE SUBSTANCE FOR THE PREVENTION OR TREATMENT OF CANCER
MX2022005388A (es) Compuestos de pirrolidina y piperidina.
EP3848039A4 (en) PHARMACEUTICAL COMPOSITION WITH A TSP1 PROTEIN INHIBITOR AS AN ACTIVE SUBSTANCE FOR THE PREVENTION OR TREATMENT OF FABRY DISEASE
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
WO2020218727A3 (ko) 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18851763

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2019558790

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18851763

Country of ref document: EP

Kind code of ref document: A2